Skip to main content
All lobbying filings

MEHLMAN CONSULTING, INC.

MEHLMAN CONSULTING, INC. filed a Q2 report for ASCENSION HEALTH ALLIANCE on July 17, 2026, reporting $80,000 in lobbying income.

Lobbying for ASCENSION HEALTH ALLIANCE

All filings by MEHLMAN CONSULTING, INC. · Everything ASCENSION HEALTH ALLIANCE has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 17, 2026
Income
$80,000
What the client paid this registrant for the period.
Client based in
Missouri

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 3

Affordable prescription drugs. Health care privacy. Health care workforce and staffing. Issues related to children's medical care. Issues related to non-profit hospital practices. H.R. 247 - Healthcare Affordability Act. Patients Deserve Price Tags Act, and issues related to health care transparency.

Affordable prescription drugs. Telehealth. Health care workforce and staffing. Medicaid coverage issues. Site-neutral payment policy. Implementation of PL 119-21

H.R. 247 - Healthcare Affordability Act; Enhanced Premium Tax Credits. H.R. 9504 -Tax Exempt Hospital Transparency Act.

 Bills named in this filing 2
  • H.R. 247
    Health Care Affordability Act of 2025
  • H.R. 9504
    Tax Exempt Hospital Transparency Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem